Literature DB >> 3310918

Whole blood assay of theophylline concentrations using immunochromatographic stick at the bedside.

A C Elias-Jones1, A L Cottle, T E Leakey, V F Larcher.   

Abstract

Blood was collected from 77 patients for estimation of theophylline concentration by whole blood assay using an immunochromatographic stick (Acculevel, Syva UK, Maidenhead, Berkshire). Results were validated by high performance liquid chromatography (HPLC). The stick method was rapid, reliable, required no technical expertise, and produced results equivalent to those obtained from assay from HPLC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310918      PMCID: PMC1778505          DOI: 10.1136/adc.62.8.836

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Pharmacokinetics of theophylline in children with asthma.

Authors:  E F Ellis; R Koysooko; G Levy
Journal:  Pediatrics       Date:  1976-10       Impact factor: 7.124

Review 2.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  Rapid estimation of plasma theophylline concentrations.

Authors:  F M Cuss; J B Palmer; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-10

4.  Re-evaluation of saliva for monitoring theophylline concentrations.

Authors:  G W Rylance; D T Beswick; R E Cullen; D G Roberts
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

5.  Homogeneous enzyme immunoassay for theophylline in serum and plasma.

Authors:  J Chang; S Gotcher; J B Gushaw
Journal:  Clin Chem       Date:  1982-02       Impact factor: 8.327

  5 in total
  2 in total

1.  Whole blood assay of theophylline concentrations using immunochromatographic stick.

Authors:  S McKenzie
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

2.  Aminophylline dosage in acute severe asthma.

Authors:  J G Gleeson; J F Price
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.